SARS-Cov-2

NEW ORLEANS – Autopsy results in otherwise healthy people who died from COVID-19 suggest that immunoglobulin therapy may be an effective treatment choice, Avindra Nath, MD, said at the American Psychiatric Association annual meeting.

CHARLOTTE, N.C. — A history of COVID-19 nearly doubled the odds of having very short sleep, according to results from a large U.S. study presented at SLEEP 2022.

SAN DIEGO — Seroconversion rates and antibody response significantly increased after a third dose of SARS-CoV-2 vaccine in patients with inflammatory bowel disease, according to a presenter at Digestive Disease Week 2022.

SAN DIEGO — The discovery of SARS-CoV-2 genomes in endoscopy samples of patients who recovered from COVID-19 suggests that the gut serves as a reservoir for the virus, according to research presented at Digestive Disease Week 2022.

SAN DIEGO — Though patients with inflammatory bowel disease have impaired humoral response after SARS-CoV-2 vaccinations, cellular responses were maintained and comparable to those of health care workers, according to study results.

SAN FRANCISCO — Treatment with inhaled interferon beta failed to improve discharge and recovery in patients hospitalized with moderate COVID-19, according to results of the phase 3 SPRINTER trial.

A significant increase in ICU admissions for adolescents aged 12 to 17 years with deliberate self-harm was reported in Australia during the COVID-19 pandemic, according to a study in JAMA Network Open.

Twenty-eight months after identifying its first case, the United States is nearing what President Joe Biden this week called “a tragic milestone”: 1 million COVID-19 deaths.

People with higher levels of narcissism were less likely to follow COVID-19 mitigation strategies, such as masking and vaccination, researchers reported in Current Psychology.

Researchers estimated that more than 200 million people globally suffer from long-term effects of COVID-19, according to a recent study.